118 related articles for article (PubMed ID: 7496336)
41. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
42. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
[TBL] [Abstract][Full Text] [Related]
43. [Detection of coagulation factor XIII in the vitreous body and periretinal membranes in proliferative retinal diseases].
Bresgen M; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(3):279-82. PubMed ID: 2198204
[TBL] [Abstract][Full Text] [Related]
44. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy.
Patel JI; Saleh GM; Hykin PG; Gregor ZJ; Cree IA
Eye (Lond); 2008 Feb; 22(2):223-8. PubMed ID: 17001327
[TBL] [Abstract][Full Text] [Related]
45. Differential expression and release of CD54 induced by cytokines.
Mickelson JK; Kukielka G; Bravenec JS; Mainolfi E; Rothlein R; Hawkins HK; Kelly JH; Smith CW
Hepatology; 1995 Sep; 22(3):866-75. PubMed ID: 7657294
[TBL] [Abstract][Full Text] [Related]
46. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.
Funatsu H; Yamashita H; Mimura T; Noma H; Nakamura S; Hori S
Eye (Lond); 2007 Mar; 21(3):377-82. PubMed ID: 16410812
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Cicik E; Tekin H; Akar S; Ekmekçi OB; Donma O; Koldaş L; Ozkan S
Ophthalmic Res; 2003; 35(5):251-5. PubMed ID: 12920337
[TBL] [Abstract][Full Text] [Related]
48. [Proliferative vitreoretinopathy. Activation of the complement system].
Grisanti S; Esser P; Weller M; Wiedemann P; Heimann K
Ophthalmologe; 1992 Feb; 89(1):50-4. PubMed ID: 1533804
[TBL] [Abstract][Full Text] [Related]
49. Increased plasma concentrations of circulating intercellular adhesion molecule-1 (cICAM-1) in patients with necrotizing pancreatitis.
Kaufmann P; Tilz GP; Smolle KH; Demel U; Krejs GJ
Immunobiology; 1996 Jul; 195(2):209-19. PubMed ID: 8877397
[TBL] [Abstract][Full Text] [Related]
50. Plasminogen in proliferative vitreoretinal disorders.
Esser P; Heimann K; Bartz-Schmidt KU; Walter P; Krott R; Weller M
Br J Ophthalmol; 1997 Jul; 81(7):590-4. PubMed ID: 9290376
[TBL] [Abstract][Full Text] [Related]
51. An immunochemical quantitative analysis of the protein pattern in physiologic and pathologic vitreous.
Clausen R; Weller M; Wiedemann P; Heimann K; Hilgers RD; Zilles K
Graefes Arch Clin Exp Ophthalmol; 1991; 229(2):186-90. PubMed ID: 2044983
[TBL] [Abstract][Full Text] [Related]
52. [Lactoferrin and transferrin--iron-binding proteins in physiological and pathological vitreous bodies].
Moter H; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1990; 87(4):336-9. PubMed ID: 2210558
[TBL] [Abstract][Full Text] [Related]
53. Macrophages in human epiretinal and vitreal membranes in patients with proliferative intraocular disorders.
Tang S; Gao R; Wu DZ
Yan Ke Xue Bao; 1996 Mar; 12(1):28-32. PubMed ID: 9275733
[TBL] [Abstract][Full Text] [Related]
54. [Macrophages and HLA-DR expression in proliferative vitreoretinopathy].
Scheiffarth OF; Tang S; Kampik A
Fortschr Ophthalmol; 1990; 87(4):340-3. PubMed ID: 2210559
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.
Yoshimura T; Sonoda KH; Sugahara M; Mochizuki Y; Enaida H; Oshima Y; Ueno A; Hata Y; Yoshida H; Ishibashi T
PLoS One; 2009 Dec; 4(12):e8158. PubMed ID: 19997642
[TBL] [Abstract][Full Text] [Related]
56. Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy.
Limb GA; Chignell AH
Br J Ophthalmol; 1999 Aug; 83(8):953-6. PubMed ID: 10413701
[TBL] [Abstract][Full Text] [Related]
57. Lymphocytes, macrophages and HLA-DR expression in vitreal and epiretinal membranes of proliferative vitreoretinopathy. An immunohistochemical study.
Tang S; Scheiffarth OF; Wildner G; Thurau SR; Lund OE
Ger J Ophthalmol; 1992; 1(3-4):176-9. PubMed ID: 1483132
[TBL] [Abstract][Full Text] [Related]
58. [Thrombospondin and its importance in proliferative retinal diseases].
Esser P; Weller M; Heimann K; Wiedemann P
Fortschr Ophthalmol; 1991; 88(4):337-40. PubMed ID: 1786916
[TBL] [Abstract][Full Text] [Related]
59. Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders.
Weller M; Clausen R; Bresgen M; Heimann K; Wiedemann P
Int Ophthalmol; 1990 Jul; 14(4):277-83. PubMed ID: 2196238
[TBL] [Abstract][Full Text] [Related]
60. Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders.
de Boer JH; Hack CE; Verhoeven AJ; Baarsma GS; de Jong PT; Rademakers AJ; de Vries-Knoppert WA; Rothova A; Kijlstra A
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3376-85. PubMed ID: 8225872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
